Combination of nanotechnology with vascular targeting agents for effective cancer therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 4, Pages 2982-2992
Publisher
Wiley
Online
2017-06-13
DOI
10.1002/jcp.26051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines
- (2017) Rana Jahanban-Esfahlan et al. GENE
- Tumor vascular infarction: prospects and challenges
- (2017) Rana Jahanban-Esfahlan et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways
- (2017) Maryam Majidinia et al. JOURNAL OF PINEAL RESEARCH
- Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
- (2017) Khaled Seidi et al. TUMOR BIOLOGY
- Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor
- (2016) Hua Jin et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application
- (2016) Pei-Xin Lai et al. BIOMATERIALS
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy
- (2016) Yuanke Li et al. JOURNAL OF CONTROLLED RELEASE
- NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors
- (2016) Flavio Curnis et al. Nano Research
- Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
- (2016) Wei Li et al. Scientific Reports
- Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model
- (2015) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo
- (2015) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy
- (2015) Manhong Li et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma
- (2015) Jinfang Zhu et al. Journal of Biomedical Nanotechnology
- Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities
- (2014) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes
- (2014) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- Emodin-Loaded Magnesium Silicate Hollow Nanocarriers for Anti-Angiogenesis Treatment through Inhibiting VEGF
- (2014) Hua Ren et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted Gold Nanoparticles as Vascular Disrupting Agents During Radiation Therapy
- (2014) R.I. Berbeco et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities
- (2014) Yuanyuan Liu et al. Nanoscale
- Anti-Angiogenesis Therapy in the Vx2 Rabbit Cancer Model with a Lipase-cleavable Sn 2 Taxane Phospholipid Prodrug using αvβ3-Targeted Theranostic Nanoparticles
- (2014) Dipanjan Pan et al. Theranostics
- Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
- (2013) Asmaa E El-Kenawi et al. BRITISH JOURNAL OF PHARMACOLOGY
- The p53 family and VEGF regulation: “It’s complicated”
- (2013) Morvarid Farhang Ghahremani et al. CELL CYCLE
- p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway
- (2013) M Farhang Ghahremani et al. CELL DEATH AND DIFFERENTIATION
- Indole conjugated silica and magnetic nanoparticles as inhibitors of HIF
- (2013) Qiu-Yun Chen et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Preparation of Curcumin-Loaded Poly(ester amine) Nanoparticles for the Treatment of Anti-Angiogenesis
- (2013) Qiuxia Ding et al. Journal of Biomedical Nanotechnology
- RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system
- (2013) Yu Sakurai et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle Delivered Vascular Disrupting Agents (VDAs): Use of TNF-Alpha Conjugated Gold Nanoparticles for Multimodal Cancer Therapy
- (2013) Mithun M. Shenoi et al. MOLECULAR PHARMACEUTICS
- Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
- (2013) Shailendra Giri et al. PLoS One
- Comparison of anti-angiogenic properties of pristine carbon nanoparticles
- (2013) Mateusz Wierzbicki et al. Nanoscale Research Letters
- Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
- (2013) Marta Cesca et al. Frontiers in Oncology
- Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo
- (2012) Keyang Huang et al. ACS Nano
- The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling
- (2012) Dongdong Sun et al. BIOMATERIALS
- Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances
- (2011) Ehud Segal et al. BIOMATERIALS
- Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
- (2011) Angelo Corti et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy
- (2011) Arijit Das et al. JOURNAL OF NANOPARTICLE RESEARCH
- Gold nanoparticle-aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus
- (2011) Wilfred Ngwa et al. MEDICAL PHYSICS
- Inhibiting angiogenesis by oral immunisation with poly(ε-caprolactone)–poly(ethylene glycol)–poly(ε-caprolactone) nanoparticle-encapsulated basic fibroblast growth factor
- (2011) JianLin Long et al. Micro & Nano Letters
- Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody
- (2011) Donghua Liu et al. MOLECULAR PHARMACEUTICS
- Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
- (2011) Rochelle R. Arvizo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature
- (2011) Tingyuan Yang et al. Nanomedicine-Nanotechnology Biology and Medicine
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Shape Effect of Carbon Nanovectors on Angiogenesis
- (2010) Padmaparna Chaudhuri et al. ACS Nano
- Disrupting established tumor blood vessels
- (2010) Mark J. McKeage et al. CANCER
- Mechanisms of resistance to antiangiogenesis therapy
- (2010) Faisal Azam et al. EUROPEAN JOURNAL OF CANCER
- Ternary biomolecular nanoparticles for targeting of cancer cells and anti-angiogenesis
- (2010) Il-Kyu Park et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- HPMA copolymer–cyclic RGD conjugates for tumor targeting☆☆☆
- (2009) Daniel B. Pike et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis
- (2009) Rania Harfouche et al. ANGIOGENESIS
- Antiangiogenic properties of silver nanoparticles
- (2009) Sangiliyandi Gurunathan et al. BIOMATERIALS
- Vascular Endothelial Growth Factor-C siRNA Delivered via Calcium Carbonate Nanoparticle Effectively Inhibits Lymphangiogenesis and Growth of Colorectal Cancer In Vivo
- (2009) Xiao-Wen He et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells
- (2009) Chandramu Chetty et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic Targeting of αvβ3Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis
- (2009) Ewelina Kluza et al. NANO LETTERS
- In vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1α) using single-walled carbon nanotubes noncovalently coated with siRNA
- (2009) Geoffrey Bartholomeusz et al. Nano Research
- Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties
- (2009) Melissa M Kemp et al. NANOTECHNOLOGY
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-β receptor inhibitor on extravasation of nanoparticles from neovasculature
- (2008) Mitsunobu R. Kano et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started